Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Continuous glucose monitoring (CGM) has provided new measures of glycemic control that link to diabetes complications. This study investigated the association between the time in range (TIR) assessed by CGM and diabetic retinopathy (DR). RESEARCH DESIGN AND METHODS: A total of 3,262 patients with type 2 diabetes were recruited. TIR was defined as the percentage of time spent within the glucose range of 3.9–10.0 mmol/L during a 24-h period. Measures of glycemic variability (GV) were assessed as well. DR was determined by using fundus photography and graded as 1) non-DR; 2) mild nonproliferative DR (NPDR); 3) moderate NPDR; or 4) vision-threatening DR (VTDR). RESULTS: The overall prevalence of DR was 23.9% (mild NPDR 10.9%, moderate NPDR 6.1%, VTDR 6.9%). Patients with more advanced DR had significantly less TIR and higher measures of GV (all P for trend <0.01). The prevalence of DR on the basis of severity decreased with ascending TIR quartiles (all P for trend <0.001), and the severity of DR was inversely correlated with TIR quartiles (r = −0.147; P < 0.001). Multinomial logistic regression revealed significant associations between TIR and all stages of DR (mild NPDR, P = 0.018; moderate NPDR, P = 0.014; VTDR, P = 0.019) after controlling for age, sex, BMI, diabetes duration, blood pressure, lipid profile, and HbA1c. Further adjustment of GV metrics partially attenuated these associations, although the link between TIR and the presence of any DR remained significant. CONCLUSIONS: TIR assessed by CGM is associated with DR in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Time in range is associated with the risk of microvascular complications and can be used for assessment of glycemic management (57).”
In the citing paper
“These results align with existing literature that emphasizes the clinical benefits of higher TIR, including reduced complications and improved overall health outcomes for individuals with diabetes19,22–24.”
From Impact of digital health interventions on glycemic control and weight management. (2025) · cites this paper as [22]
In the citing paper
“Most recently, the beneficial effects of new medications, such as sodium glucose cotransporter-2 (SGLT-2) agents have helped individuals with type 1 diabetes increase TIR (49-51).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [49]
In the citing paper
“TIR has been found to be strongly associated with the development or progression of diabetic retinopathy and microalbuminuria in type 1 and type 2 DM.16 17”
From Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease (2020) · cites this paper as [17]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Wilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 2×
“However, HbA1c is unreliable in patients with anemia, hemoglobinopathies, or iron deficiency, and in patients who are pregnant (7).”
BackgroundSelf-citationContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Cited by
Items 201–300 of 568
Liu, L., Ke, W., Xu, L., Li, H., Liu, J., Wan, X., Liu, J., Deng, W., Cao, X., Xiao, H., et al. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13355 · Cited by 16
Takao, T., Takahashi, K., Yoshida, Y., Kushiyama, A., Onishi, Y., Tahara, T., Shimmei, A., Kikuchi, T., Suka, M., Yanagisawa, H., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13194 · Cited by 16
Glucose outcomes of a learning-type artificial pancreas with an unannounced meal in type 1 diabetes
Song, L., Liu, C., Yang, W., Zhang, J., Kong, X., Zhang, B., Chen, X., Wang, N., Shen, D., Li, Z., et al. (2020) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2020.105416 · Cited by 16
Issar, T., Tummanapalli, S. S., Kwai, N. C. G., Chiang, J. C. B., Arnold, R., Poynten, A. M., Markoulli, M. P., & Krishnan, A. V. (2020) · Diabetic Medicine · doi:10.1111/dme.14306 · Cited by 16
Cheung, Y.-M. M., Cromwell, G. E., Tolaney, S. M., Min, L., & McDonnell, M. E. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06476-1 · Cited by 16
Yin, X., Zhu, W., Liu, C., Yao, H., You, J., Chen, Y., Ying, X., & Li, L. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221099337 · Cited by 15
Self-citationChinese Guidelines for Medical Nutrition Therapy for Patients with Diabetes (2022 Edition).
(2024) · PubMed Central · doi:10.6133/apjcn.202406_33(2).0001 · Cited by 15
Frías, J. P., González-Gálvez, G., JOHNSSON, E. K., Maaske, J., Testa, M. A., Simonson, D. C., Dronamraju, N., García‐Sánchez, R., & Peters, A. L. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13997 · Cited by 15
Flash glucose monitoring system in special situations
Rigon, F., Ronsoni, M. F., Vianna, A. G. D., Schiavon, L. D. L., Hohl, A., & van de Sande‐Lee, S. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000479 · Cited by 15
Ren, Q., Zhang, P., Pang, W., Ma, Y., Gong, S., Ba, T., Liu, W., Zhang, F., Zhang, X., Zhang, R., et al. (2023) · Diabetes · doi:10.2337/db22-0566 · Cited by 14
Utilizing the New Glucometrics: A Practical Guide to Ambulatory Glucose Profile Interpretation
Doupis, J., & Horton, E. S. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.1.20 · Cited by 14
Shen, Y., Wang, C., Wang, Y., Lu, J., Chen, L., Zhang, L., Lu, W., Zhu, W., Hu, G., Xia, T., et al. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001740 · Cited by 14
Self-citationLee, S., Lee, S., Kim, K. M., & Shin, J. H. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1145470 · Cited by 14
Tao, R., Yu, X., Lu, J., Wang, Y., Lu, W., Zhang, Z., Li, H., & Zhou, J. (2023) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-023-01254-3 · Cited by 14
Self-citationMartens, T. W., Bergenstal, R. M., Pearson, T. L., Carlson, A. L., Scheiner, G., Carlos, C., Liao, B., Syring, K. E., & Pollom, R. D. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1851946 · Cited by 14
Bae, J. C., Kwak, S. H., Kim, H. J., Kim, S.-Y., Hwang, Y., Suh, S., Hyun, B. J., Cha, J. E., Won, J. C., & Kim, J. H. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0016 · Cited by 14
Dowd, R., Jepson, L. H., Green, C. R., Norman, G. J., Thomas, R., & Leone, K. (2023) · JMIR Diabetes · doi:10.2196/43991 · Cited by 14
Takagi, A., Kusunoki, Y., Ohigashi, M., Osugi, K., Inoue, C., Inoue, M., Tsunoda, T., Kadoya, M., Konishi, K., Katsuno, T., et al. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02214-9 · Cited by 13
Pei, X., Ba, M., Yang, T., Xuan, S., Huang, D., Qi, D., Lu, D., Huang, S., & Li, Z. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.1.19 · Cited by 13
Wang, Y., Lu, J., Shen, Y., Ni, J., Zhang, L., Lu, W., Zhu, W., Bao, Y., & Zhou, J. (2022) · Endocrine · doi:10.1007/s12020-022-03038-3 · Cited by 13
Self-citationMolfetta, S. D., Rossi, A., Assaloni, R., Cherubini, V., Consoli, A., Bartolo, P. D., Guardasole, V., Laurenzi, A., Lombardo, F., Maffeis, C., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109867 · Cited by 13
Guo, K., Zhang, L., Ye, J., Niu, X., Jiang, H., Gan, S., Zhou, J., Yang, L., & Zhou, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.972785 · Cited by 13
Self-citationHelleputte, S., Calders, P., Rodenbach, A., Marlier, J., Verroken, C., Backer, T. L. M. D., & Lapauw, B. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01717-z · Cited by 13
Kawaguchi, Y., Hajika, Y., Rinka, M., Masumoto, K., Sawa, J., Hamazaki, K., & Kumeda, Y. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14151 · Cited by 13
Cutruzzolà, A., Parise, M., Scavelli, F. B., Barone, M., Gnasso, A., & Irace, C. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821993178 · Cited by 13
Wang, Y., Li, H., Gao, H., Xu, X., Cai, T., Wang, H., Zhou, Y., Huang, R., Su, X., & Ma, J. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109171 · Cited by 13
Liang, B., Koye, D. N., Hachem, M., Zafari, N., Braat, S., & Ekinci, E. I. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.849725 · Cited by 13
Mandla, R., Schroeder, P. H., Florez, J. C., Mercader, J. M., & Leong, A. (2024) · Diabetes Care · doi:10.2337/dc23-1691 · Cited by 12
Hayek, A. A., & Dawish, M. A. A. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241301750 · Cited by 12
Tokutsu, A., Okada, Y., Mita, T., Torimoto, K., Wakasugi, S., Katakami, N., Yoshii, H., Uriu, K., Nishida, K., Arao, T., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14550 · Cited by 12
Insulin Titration Guidelines for Patients With Type 1 Diabetes: It Is About Time!
Walsh, J. S. A., Roberts, R., Bailey, T. S., & Heinemann, L. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221087261 · Cited by 12
Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
Yoo, J. H., & Kim, J. H. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0256 · Cited by 12
Wei, Y., Liu, C., Liu, Y., Zhang, Z., Feng, Z., Yang, X., Liu, J., Lei, H., Zhou, H., Shen, Q., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01718-y · Cited by 12
Research progress in the application of time in range: more than a percentage
Wan, J., Lu, J., Li, C., Ma, X., & Zhou, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002582 · Cited by 12
Self-citationWang, Y., Lu, J., Ni, J., Wang, M., Shen, Y., Lu, W., Zhu, W., Bao, Y., & Zhou, J. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3639 · Cited by 12
Self-citationTakuma, K., Fuchigami, A., Shigiyama, F., Kumashiro, N., & Hirose, T. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15089 · Cited by 12
Matabuena, M., Félix, P., Ditzhaus, M., Vidal, J. C., & Gudé, F. (2023) · The American Statistician · doi:10.1080/00031305.2023.2200512 · Cited by 12
Dong, S., Wang, L., Zhao, C., Zhang, R., Gao, Z., Jiang, L., Guo, Y., Zhou, H., & Xu, S. (2023) · BMC Neurology · doi:10.1186/s12883-023-03242-2 · Cited by 12
Tweden, K. S., Deiss, D., Rastogi, R., Addaguduru, S., & KAUFMAN, F. R. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0342 · Cited by 12
Boscari, F., D’Anna, M., Bonora, B. M., Tresso, S., Cappellari, R., Avogaro, A., Bruttomesso, D., & Fadini, G. P. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01278-6 · Cited by 12
Mbanya, J. C., Lamptey, R., Uloko, A. E., Ankotché, A., Moleele, G., Mohamed, G. A., Ramracheya, I., Ramaiya, K. L., Ndiweni, M., Mbaye, M. N., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00958-z · Cited by 12
Continuous Glucose Monitoring Use in Clinical Trials for On-Market Diabetes Drugs
Fox, B. Q., Benjamin, P. F., Aqeel, A., Fitts, E., Flynn, S., Levine, B., Maslak, E., Milner, R. L., Ose, B. M., Poeschla, M., et al. (2021) · Clinical Diabetes · doi:10.2337/cd20-0049 · Cited by 12
AGP and Nutrition – Analysing postprandial glucose courses with CGM
Kröger, J., Siegmund, T., Schubert-Olesen, O., Keuthage, W., Lettmann, M., Richert, K., & Pfeiffer, A. F. H. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108738 · Cited by 12
Differences in Glucose Readings Between Right Arm and Left Arm Using a Continuous Glucose Monitor
Kawakatsu, S., Liu, X., Tran, B., Tran, B. P., Manzanero, L., Shih, E., Shek, A., & Lim, J. J. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211008838 · Cited by 12
Ying, L., Shen, Y., Zhang, Y., Wang, Y., Liu, Y., Yin, J., Wang, Y., Yin, J., Zhu, W. M., Bao, Y., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.696156 · Cited by 12
Self-citationBAJAJ, H. S., Chu, L., Bansal, N., Brown, R. E., Dhillon, G. S., Gupta, R., Bhela, J. S., Padda, J., Khandwala, H. M., Venn, K., et al. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.02.003 · Cited by 12
Blevins, T., Lane, W. S., Rodbard, D., Sindelar, D. K., Fan, L., Ellinor, K., Ilag, L. L., Ly, T. T., & Johnson, J. L. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0030 · Cited by 12
Cao, W. J., Zou, J., Gao, M., Huang, J., Li, Y., Li, N., Qian, L., Zhang, Y., Ji, M., & Liu, Y. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108831 · Cited by 11
Colás, A., Varela, M. G., Mráz, M., Novák, D., Cuesta–Frau, D., Vigil, L., Beneš, M., Pelikánová, T., Haluzík, M., Burda, V., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3287 · Cited by 11
Ye, J., Deng, J., Liang, W., Luo, H., Mei, W., Liu, L., Wang, M., & Shu, Y. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13876 · Cited by 11
Huang, L., Wang, Z., Pan, Y., Zhou, K., & Zhong, S. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s458084 · Cited by 11
Díaz-Soto, G., Pérez-López, P., Fernández-Velasco, P., Bahillo-Curieses, P., de la Marca, M. D. L. O. N., Jimenez, R., & de Luis, D. A. (2024) · Endocrine · doi:10.1007/s12020-024-03846-9 · Cited by 11
Xu, S.-Y., Ke-Li, Zhang, Z., Liu, C., Guo, Q., Lu, B., Gu, P., & Shao, J. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108684 · Cited by 11
Peterkova, V. A., As, A., Mayorov, A. Y., Galstyan, G. R., Лаптев, Д. Н., & Chernikova, N. A. (2021) · Diabetes Mellitus · doi:10.14341/dm12753 · Cited by 11
Time in Range: Ein neuer Parameter – komplementär zum HbA 1c
Danne, T., Kordonouri, O., Biester, T., Siegmund, T., Kröger, J., Bramlage, P., & Haak, T. (2019) · Deutsches Ärzteblatt · doi:10.3238/persdia.2019.10.25.01 · Cited by 11
Zhao, W., Lu, J., Zhang, L., Lu, W., Zhu, W., Bao, Y., & Zhou, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002140 · Cited by 11
Self-citationAssociation between low‐carbohydrate diets and continuous glucose monitoring‐derived time in ranges
Osugi, K., Kusunoki, Y., Ohigashi, M., Kusunoki, K., Inoue, C., Inoue, M., Takagi, A., Tsunoda, T., Kadoya, M., Konishi, K., et al. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.13999 · Cited by 10
The Relationship Between Glycated Albumin and Time in Tight Range in Type 2 Diabetes
Ni, J., Han, W., Wang, Y., Yu, J., Lu, W. D., Wang, Y., Ma, X., Lu, J., & Zhou, J. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70073 · Cited by 10
Self-citationAssociation of time in tight range and 1,5‐anhydroglucitol in type 2 diabetes
Su, H., Ni, J., Peng, D., He, X., Lu, W., Zhu, W., Wang, Y., Ma, X., Lu, J., & Zhou, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16515 · Cited by 10
Self-citationReduced rates of diabetic retinopathy complications with use of continuous glucose monitoring
Alsoudi, A. F., Wai, K. M., Koo, E. B., Koo, E., Mruthyunjaya, P., & Rahimy, E. (2025) · Scientific Reports · doi:10.1038/s41598-025-08971-7 · Cited by 10
Guidelines on primary healthcare for type 2 diabetes in China, 2025
Jia, W., Zhu, D., Guo, L., Chen, L., Cai, C., & Song, J. (2025) · Family Medicine and Community Health · doi:10.1136/fmch-2025-003765 · Cited by 10
Self-citationZhu, D., Cheng, X., & Ding, N. (2023) · International Journal of Ophthalmology · doi:10.18240/ijo.2023.06.13 · Cited by 10
The Prognostic Value of Time in Range in Type 2 Diabetes
Selvin, E. (2021) · Diabetes Care · doi:10.2337/dci20-0066 · Cited by 10
Hu, K., Peng, H., Ma, Y., Li, X., Bai, R., Wang, J., Xu, J., Fu, L., Liu, J., Bai, J., et al. (2021) · Blood Purification · doi:10.1159/000513162 · Cited by 10
Guo, J., Wang, J., Zhao, Z., & Yu, L. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-2198 · Cited by 10
Time in range is a tool for assessing the quality of glycemic control in diabetes
Суплотова, Л. А., Сергеевна, С. А., Романова, Н. В., & Shestakova, M. V. (2021) · Diabetes Mellitus · doi:10.14341/dm12703 · Cited by 10
Association Between Time in Range and HbA1c in Japanese Patients With Type 2 Diabetes Mellitus
Kurozumi, A., Okada, Y., Mita, T., Wakasugi, S., Katakami, N., Yoshii, H., Kanda, K., Nishida, K., Mine, S., Tanaka, Y., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109836 · Cited by 10
Zhou, Y., Mai, X., Deng, H., Yang, D., Zheng, M., Huang, B., Xu, L., Weng, J., Xu, W., & Yan, J. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13296 · Cited by 10
Calhoun, P. M., Price, D. A., & Beck, R. W. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0471 · Cited by 10
Leveraging the future of diagnosis and management of diabetes: From old indexes to new technologies
Meneses, M. J., Patarrão, R. S., Pinheiro, T., Coelho, I., Carriço, N., Marques, A. C., Romão, A., Nabais, J. M. V., Fortunato, E. M. C., Raposo, J. F., et al. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13934 · Cited by 10
Bovee, L. B., & Hirsch, I. B. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0028 · Cited by 10
Gullaksen, S., Vernstrøm, L., Sørensen, S. S., Funck, K. L., Petersen, L., Bek, T., Poulsen, P. L., & Laugesen, E. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109039 · Cited by 9
Inoue, M., Kusunoki, Y., Ohigashi, M., Osugi, K., Inoue, C., Otsuka, A., Azuma, D., Ikeda, H., Tamada, D., Inagaki, T., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16511 · Cited by 9
Godneva, A., Phillip, M., Segal, E., & Shilo, S. (2026) · Diabetes Care · doi:10.2337/dc25-2154 · Cited by 9
Salam, M., Bailey, R. J., Calhoun, P. M., McGill, J. B., Bergenstal, R. M., Price, D. A., & Beck, R. W. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0387 · Cited by 9
Block, C. E. M. D., CHENG, A. Y. Y., Christensen, T. B., Patted, U. R. H., & Ginovker, A. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01429-x · Cited by 9
Sun, R., Duan, Y., Zhang, Y., Feng, L., Ding, B., Yan, R., Ma, J., & Su, X. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01432-2 · Cited by 9
Hallström, S., Hirsch, I. B., Ekelund, M., Sofizadeh, S., Albrektsson, H., Dahlqvist, S., Svensson, J., & Lind, M. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0577 · Cited by 9
Effects of Variability in Glycemic Indices on Longevity in Chinese Centenarians
Ji, S.-H., Dong, C., Chen, R., Shen, C., Xiao, J., Gu, Y., & Gao, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.955101 · Cited by 9
Lee, Y., Kim, M., & Kim, J. H. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0032 · Cited by 9
Deshmukh, H., Wilmot, E. G., Pieri, B. A., Choudhary, P., Shah, N. Z., Gregory, R., Kilvert, A., Lumb, A. N., Christian, P., Barnes, D., et al. (2022) · Diabetic Medicine · doi:10.1111/dme.14942 · Cited by 8
Sugimoto, T., Tokuda, H., Miura, H., Kawashima, S., Omura, T., Ando, T., Kuroda, Y., Matsumoto, N., Fujita, K., Uchida, K., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15275 · Cited by 8
Peralta, F. G., Gea, I. L., Duque, N., Artime, E., & Santos, M. R. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02943-5 · Cited by 8
Kim, S., Park, S., Lee, J. A., Cho, S. H., Oh, R., Kim, J. Y., Lee, Y., Kim, G., Hur, K. Y., Kim, J. H., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06442-2 · Cited by 8
Smetana, G. W., Nathan, D. M., Dugdale, D. C., & Burns, R. B. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0946 · Cited by 8
Philis‐Tsimikas, A., Aroda, V. R., Block, C. E. M. D., Billings, L. K., Liebl, A., Sivarathinasami, R., D’Cruz, J. M., & Lingvay, I. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221149041 · Cited by 8
Tao, R., Li, H., Lu, J., Huang, Y., Wang, Y., Lu, W., Shao, X., Zhou, J., & Yu, X. (2024) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-024-03120-0 · Cited by 8
Self-citationThe “Time in Range” Concept in Ophthalmology
Kozak, I., & Stewart, M. W. (2023) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2023.08.013 · Cited by 8
One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus
Evans, M., Morgan, A. R., & Bain, S. C. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01061-7 · Cited by 7
Wu, C. C., Wu, K. C., José, A. S., & Novin, N. (2021) · JMIR Diabetes · doi:10.2196/30626 · Cited by 7
Hu, Y., Zhang, P., Ding, B., Cao, X., Zhong, Y., Sun, Y.-X., Lee, K.-O., & Ma, J. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00208-0 · Cited by 7
Hayek, A. A., Mashali, M. A., & Dawish, M. A. A. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01569-w · Cited by 7
Sheng, T., Offringa, R., Kerr, D. E., Clements, M. A., Fischer, J., Parks, L. J., & Greenfield, M. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819873641 · Cited by 7
Optimizing Diabetes Care With the Standardized Continuous Glucose Monitoring Report
Chun, J. H., & O’Neill, M. S. (2020) · Clinical Diabetes · doi:10.2337/cd19-0066 · Cited by 7
The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring
Kushner, P. R., & Kruger, D. F. (2020) · Clinical Diabetes · doi:10.2337/cd19-0093 · Cited by 7
Zhou, L., Luo, Y., Wang, Y., Cheng, Y., Zhang, R., Zhang, S., Gong, S., Han, X., & Ji, L. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2023.1172208 · Cited by 6
Liu, Z., Lin, B., Chen, D., Yang, Y., Jiang, W., Yang, D., Yan, J., Yao, B., Yang, X., & Xu, W. (2024) · Endocrine · doi:10.1007/s12020-024-04083-w · Cited by 6
Correlation between key indicators of continuous glucose monitoring and the risk of diabetic foot
Geng, X., Chen, S.-F., Wang, F.-Y., Yang, H., Zhao, Y., Xu, Z., & Yang, Y. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i3.99277 · Cited by 6
Deng, B.-Y., Zhao, Y., & Liu, J.-S. (2025) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2025.101579 · Cited by 6
Kinny, F., Läer, S., & Obarčanin, E. (2025) · PLOS Digital Health · doi:10.1371/journal.pdig.0001087 · Cited by 6
Metadata
- Authors
- Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., & Jia, W.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Zhou, Jian
- Jia, Weiping
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-09-10
- Volume
- 41
- Issue
- 11
- Pages
- 2370-2376
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2891930016
- Cited by
- 517
- References
- 32
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 61 · 2023: 70 · 2022: 87 · 2021: 85 · 2020: 71 · 2019: 40 · 2018: 1
- FWCI
- 39.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81100590)
- Shanghai Municipal Education Commission (20161430)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- time in range, continuous glucose monitoring, diabetic retinopathy, type 2 diabetes, glycemic variability, glycemic control, non-proliferative diabetic retinopathy, vision-threatening diabetic retinopathy, retinopathy severity
- MeSH terms
- Aged, Blood Glucose, Blood Pressure, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Fundus Oculi, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Reference Values, Retrospective Studies, Time Factors, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.